{
    "eid": "2-s2.0-85107993843",
    "title": "Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer",
    "cover-date": "2021-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Biosimilar",
        "Metastatic breast cancer",
        "Overall survival",
        "Trastuzumab"
    ],
    "authors": [
        "Hope S. Rugo",
        "Eduardo J. Pennella",
        "Unmesh Gopalakrishnan",
        "Miguel Hernandez-Bronchud",
        "Jay Herson",
        "Hans Friedrich Koch",
        "Subramanian Loganathan",
        "Sarika Deodhar",
        "Ashwani Marwah",
        "Alexey Manikhas",
        "Igor Bondarenko",
        "Guzel Mukhametshina",
        "Gia Nemsadze",
        "Joseph D. Parra",
        "Maria Luisa T. Abesamis-Tiambeng",
        "Kakhaber Baramidze",
        "Charuwan Akewanlop",
        "Ihor Vynnychenko",
        "Virote Sriuranpong",
        "Gopichand Mamillapalli",
        "Sirshendu Roy",
        "Eduardo Patricio Yanez Ruiz",
        "Abhijit Barve",
        "Adolfo Fuentes-Alburo",
        "Cornelius F. Waller"
    ],
    "citedby-count": 3,
    "ref-count": 23,
    "ref-list": [
        "Targeted therapy of cancer: new prospects for antibodies and immunoconjugates",
        "Monoclonal antibodies and Fc fragments for treating solid tumors",
        "Monoclonal antibodies in cancer therapy",
        "Monoclonal antibodies in gynecological cancer: a critical point of view",
        "Barriers to the use of trastuzumab for HER2+ breast cancer and the potential impact of biosimilars: a physician survey in the United States and emerging markets",
        "A clinician's guide to biosimilars in oncology",
        "Worldwide experience with biosimilar development",
        "The evolution of biosimilars in oncology, with a focus on trastuzumab",
        "Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods",
        "Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications",
        "Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2",
        "The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars",
        "Improving access to cancer treatments: the role of biosimilars",
        "Effect of a proposed trastuzumab biosimilar compared with trastuzumab on overall response rate in patients with ERBB2 (HER2)-positive metastatic breast cancer: a randomized clinical trial",
        "A bioequivalence study for Hercules, a biosimilar trastuzumab candidate in development [BPS 292P]",
        "A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL-1401O vs. EU-trastuzumab and US-trastuzumab",
        "Biosimilar trastuzumab-dkst monotherapy versus trastuzumab monotherapy after combination therapy: Toxicity, efficacy, and immunogenicity from the phase 3 Heritage trial at 48 weeks of follow-up",
        "Three-year follow-up from a phase 3 study of SB3 (A trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2-positive breast cancer",
        "Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer",
        "Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): Two highly active therapeutic regimens",
        "Biosimilars in oncology: Effects on economy and therapeutic innovations"
    ],
    "affiliation": [
        {
            "affiliation-city": "Canonsburg",
            "@id": "60274569",
            "affilname": "Viatris, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60274569",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Gaithersburg",
            "@id": "60116226",
            "affilname": "MaxCyte, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60116226",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Quezon City",
            "@id": "60071484",
            "affilname": "St. Luke's Medical Center Quezon City",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071484",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Dnipro",
            "@id": "60070090",
            "affilname": "Dnipro State Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60070090",
            "affiliation-country": "Ukraine"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "60029881",
            "affilname": "UCSF Helen Diller Family Comprehensive Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029881",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Freiburg im Breisgau",
            "@id": "60024805",
            "affilname": "Universit\u00e4tsklinikum Freiburg",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024805",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Sumy",
            "@id": "60016511",
            "affilname": "Sumy State University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016511",
            "affiliation-country": "Ukraine"
        },
        {
            "affiliation-city": "Temuco",
            "@id": "60012035",
            "affilname": "Universidad de la Frontera",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012035",
            "affiliation-country": "Chile"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60006183",
            "affilname": "Johns Hopkins Bloomberg School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006183",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Saint Petersburg",
            "@id": "126644584",
            "affilname": "City Clinical Oncology Dispensary",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126644584",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Manila",
            "@id": "124645431",
            "affilname": "Cardinal Santos Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124645431",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Nasik",
            "@id": "123351617",
            "affilname": "Curie Manavata Cancer Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/123351617",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Bengaluru",
            "@id": "121837736",
            "affilname": "Biocon Research Limited",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/121837736",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Barcelona",
            "@id": "120952129",
            "affilname": "GenesisCare Corachan Institute of Oncology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120952129",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Tbilisi",
            "@id": "117925630",
            "affilname": "Golden Fleece 21 Century Health House Ltd",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117925630",
            "affiliation-country": "Georgia"
        },
        {
            "affiliation-city": "Vijayawada",
            "@id": "114003460",
            "affilname": "City Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114003460",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Kazan",
            "@id": "112755585",
            "affilname": "Regional Clinical Oncological Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112755585",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Tbilisi",
            "@id": "101407268",
            "affilname": "Institute of Clinical Oncology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101407268",
            "affiliation-country": "Georgia"
        }
    ],
    "funding": [
        "Viatris Inc",
        "Viatris Inc.",
        "Biocon Limited"
    ]
}